Bill Ackman's bets on Valeant and Herbalife may have been a bridge too far for investors. The Wall Street Journal is reporting that after three years of poor performance most investors have left Pershing Square. Redemptions have been steady since last year, according to people familiar with the fund.

Assets under management at the firm were just over